Heritage Group, a healthcare-focused private equity firm, today announced the final closing of Heritage Healthcare Innovation Fund IV (“Fund IV” or the “Fund”) at over $370 million, marking another significant milestone in the firm’s continued growth. Fund IV builds on Heritage Group’s successful strategy of making minority and majority investments in solution-oriented, high-growth healthcare services and technology businesses that address the industry’s most pressing challenges.

“We are grateful for the continued support from our longtime investors and excited to welcome several new limited partners to Fund IV,” said Jesse Bland, Partner at Heritage Group. “Their confidence reflects the strength of our strategic model and our ability to identify and scale businesses across some of the highest growth subsectors of the healthcare ecosystem.”

Heritage is backed by leading healthcare organizations, including major health systems operating more than 800 hospitals, payers insuring over 75 million lives, and other key healthcare service providers.

“Our strategic investors aren’t just capital providers—they’re true partners in how we source, evaluate, and grow businesses,” said Bryan Bui, Partner at Heritage Group. “We work hard to maintain a two-way dialogue with our limited partners, ensuring they have early and direct access to emerging innovation while also bringing their insights into every stage of our investment process.”

Heritage Group’s deep strategic engagement model ensures that their health system and payer limited partners add value throughout the investment lifecycle—from sourcing and diligence to portfolio company growth and commercialization. This strategic investment approach provides proprietary insights and real-time market intelligence, enabling Heritage to take a thematic approach to investing by targeting segments of the healthcare industry positioned for meaningful and sustained growth.

“Heritage enables us to engage directly with some of the most forward-thinking healthcare companies in the market,” said Tim Hingtgen, CEO of Community Health Systems. “Their ability to surface emerging trends early, connect us with innovative solutions, and create meaningful opportunities for strategic collaboration across the ecosystem makes them a uniquely valuable partner.”

Heritage Group’s portfolio spans several high-impact themes including the shift to lower-cost sites of care, such as ambulatory infusion (TwelveStone) and home-based care (Upward Health); enabling value-based care through companies like Curana Health and Wellvana; supporting health systems through outsourced clinical services (Equum, a leader in teleICU and telenursing, and Shearwater Health, a clinical process outsourcer); and expanding access to care via platforms such as MDLIVE and Connections Health Solutions.

“Heritage has been an invaluable partner to our team—delivering strategic value well beyond capital,” said David Siegel, CEO of Nationwide Medical, a Heritage Group portfolio company. “Their deep understanding of the healthcare landscape, collaborative approach, and strategic connectivity have helped us accelerate growth and expand our impact in meaningful ways.”

About Heritage Group

Heritage Group is a Nashville, Tennessee-based, healthcare-focused private equity firm with more than 40 years of experience financing and operating healthcare companies. Heritage has over $1 billion of assets under management and seeks to make majority and minority investments in high-growth healthcare services and healthcare technology businesses that address the challenges of the U.S. healthcare system. The firm's limited partners include some of the leading healthcare organizations in the nation, including large provider systems, payers, and healthcare service providers, which collectively operate over 800 hospitals and insure more than 75 million lives. For more information, visit www.heritagegroupusa.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724116955/en/

Heritage Group’s deep strategic engagement model ensures that their health system and payer limited partners add value throughout the investment lifecycle—from sourcing and diligence to portfolio company growth and commercialization.